Q4 2021 Vivoryon Therapeutics NV Earnings Call Transcript

Apr 28, 2022 / 01:00PM GMT
Operator

Dear, ladies and gentlemen, welcome to the conference call of Vivoryon Therapeutics N.V. At our customer's request, this conference call will be recorded. (Operator Instructions)

May I now hand your call over to Manuela, who will start today's conference. Please go ahead.

Manuela Bader - Vivoryon Therapeutics N.V. - Director of IR & Communications

Thank you, Cheryl. Good afternoon, and thank you for joining us today for Vivoryon's conference call to discuss the company's full year 2021 results and operational progress.

This morning, Vivoryon issued a press release, which is posted on the company's website at www.vivoryon.com.

On the call with me today are Ulrich Dauer, Chief Executive Officer of Vivoryon; and Florian Schmid, our Chief Financial Officer. Also with us on today's call and available for questions is Michael Schaeffer, our Chief Business Officer.

We will begin today's call with opening remarks from Ulrich on Vivoryon's approach to overcoming

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot